The Discounted Cash Flow (DCF) valuation of Globus Medical Inc (GMED) is 110.79 USD. With the latest stock price at 74.29 USD, the upside of Globus Medical Inc based on DCF is 49.1%.
Based on the latest price of 74.29 USD and our DCF valuation, Globus Medical Inc (GMED) is a buy. buying GMED stocks now will result in a potential gain of 49.1%.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 9.6% | 8.3% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 78.54 - 200.32 | 110.79 |
| Upside | 5.7% - 169.6% | 49.1% |